MY ACCOUNT | NEWSLETTER |

Beyond Advice: PetPace and TelmyVet Redefine Telemedicine for Pets with Launch of Groundbreaking Quality-of-Life Consultation


TelmyVet and PetPace jointly announced today the launch of a pioneering Quality-of-Life Consultation, a virtual care service designed to support pets and their families during the most vulnerable stage of life. By combining TelmyVet’s advanced telemedicine platform with the award-winning PetPace wearable AI and machine learning dog health monitor, this new service offers a compassionate, data-driven approach to end-of-life care.

“It’s critical that families feel supported through every step of end-of-life care,” said Emily Piché, TelmyVet program director. “This service creates space for meaningful conversations about hospice care, anticipatory grief, and caregiver burden.”

Redefining Hospice and Palliative Support for Pets

Caring for pets in their final life stage is emotionally complex. The Quality-of-Life Consultation provides a safe, virtual space for pet parents to connect with veterinary professionals, receive guidance, and make informed decisions—reducing the stress of in-clinic visits for pets with limited mobility or chronic illness.

“When evaluating Quality-of-Life, access to near real time health alerts and continuous vital sign tracking like HRV, sleep, pain, and wellness scores changes everything,” said Dr. Asaf Dagan, chief veterinary scientist at PetPace. “It provides a holistic view of the pet’s well-being.”

Objective, Real-Time Health Monitoring

At the core of this service is the PetPace smart dog collar—a clinically validated device that tracks vital signs, mobility, posture, behavior, and location. It is the only veterinarian-grade wearable that measures Heart Rate Variability (HRV), a critical indicator of pain and stress. Through advanced analytics, veterinary teams can monitor health trends over time rather than relying on isolated data points.

Empowering Veterinary Teams with Technology and Compassion

Designed by veterinary experts, the consultation equips practices with customizable pain scales, QOL assessment forms, and educational tools to guide clients with clarity and compassion.

“Veterinary care shouldn’t end when a client leaves the clinic,” said Dr. Chris Armstrong, veterinarian and industry advisor. “The Quality-of-Life consult empowers teams to extend care virtually, while streamlining workflow and maintaining high standards of care.”

Looking Ahead: Consult+ Series and Future Integrations

The Quality-of-Life Consultation is the first offering in TelmyVet's upcoming Consult+ series. Future services will include senior care, chronic disease management, epilepsy, reproduction, pain management, behavior, weight control, and more—all supported by the real-time health data provided by PetPace technology.

About PetPace

PetPace, based in Burlington, MA, is the leading provider of advanced pet health monitoring solutions made by vets for home use dedicated to enhancing pet wellness through advanced wearable technology. Our patented AI/ML-powered smart collar continuously collects real-time physiological and behavioral data, enabling early detection of health issues and redefining proactive pet care. Composed of veterinarians, IoT professionals, engineers, AI experts, and data specialists, our team collaborates with top universities and research institutes worldwide. Trusted by veterinarians, researchers, and pet owners, PetPace is dedicated to protecting and improving pet health. For more information visit: https://petpace.com/

About TelmyVet

TelmyVet is a Canadian-based telemedicine platform that empowers veterinary practices to deliver accessible, expert-led virtual care. Its tools support continuity of care for pets and peace of mind for pet parents.


Source: www.telmyvet.com

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Dr. Marjorie Bercier Publishes Study on Novel Diagnostic Approach for Prevalent Elephant Virus

Like0
Dislike0

FDA Approves BRAVECTO® QUANTUM (Fluralaner for Extended-Release Injectable Suspension) from Merck Animal Health

Like0
Dislike0

Feline injection site sarcomas

Like0
Dislike0

C-reactive protein concentrations in canine acute pancreatitis

Like0
Dislike0

A retrospective clinical investigation of the safety and adverse effects of pantoprazole in hospitalized ruminants

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top